Evidence map›Paper›PMID 35864237›Full record

ArticleCellular and molecular life sciences : CMLS2022

H

Maria Petrosino, Karim Zuhra, Jola Kopec, Andrew Hutchin, Csaba Szabo, Tomas Majtan

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. L-cysteine inhibited the growth ofApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Fueling Death: The Metabolic Control of Ferroptosis.Advances in experimental medicine and biology · 2026
    Review
  7. Review
  8. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  9. Intersection of HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Pills of Multi-Target HInternational journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maria Petrosino *Department of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musee 18, PER17, 1700, Fribourg, Switzerland.
Karim Zuhra *Department of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musee 18, PER17, 1700, Fribourg, Switzerland.
Jola KopecStructural Biology Unit, Evotec Ltd, 114 Innovation Drive, Abingdon, OX14 4RZ, UK.
Andrew HutchinStructural Biology Unit, Evotec Ltd, 114 Innovation Drive, Abingdon, OX14 4RZ, UK.
Csaba SzaboDepartment of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musee 18, PER17, 1700, Fribourg, Switzerland.
Tomas MajtanDepartment of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musee 18, PER17, 1700, Fribourg, Switzerland. tomas.majtan@unifr.ch.ORCID http://orcid.org/0000-0002-2751-2124
University of Fribourg · CHEvotec (United Kingdom) · GB

Funding

Krebsliga Schweiz KLS-4504-08-2018
6 · The paper itself

Abstract

Cystathionine beta-synthase (CBS) is a pivotal enzyme of the transsulfuration pathway responsible for diverting homocysteine to the biosynthesis of cysteine and production of hydrogen sulfide (H

Indexed as

Cystathionine beta-SynthaseHydrogen SulfideAminooxyacetic AcidCysteineHumansSerineAminooxyacetic AcidCystathionine beta-SynthaseCysteineHydrogen SulfideSerineCancerDown syndromeEnzyme kineticsHomocystinuriaHydrogen sulfidePyridoxal phosphate

Identifiers

PMID35864237
PMCPMC9304066
OpenAlexW4286382735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.